- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Guerbet (GRBT)"Guerbet stock price live, this page displays EPA GRBT stock exchange data. View the GRBT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Guerbet real time stock price chart below.
What Is the Guerbet Stock Price Today?
The Guerbet stock price today is 25.10.
What Is the Stock Symbol for Guerbet?
The stock symbol for Guerbet is ""GRBT.""
What Stock Exchange Does Guerbet Trade On?
Guerbet is listed and trades on the Paris stock exchange.
Is Guerbet a Good Stock to Buy?
Determining whether Guerbet—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRBT quote. (ISIN: FR0000032526)"
What Is the Guerbet Stock Price Today?
The Guerbet stock price today is 25.10.
What Is the Stock Symbol for Guerbet?
The stock symbol for Guerbet is ""GRBT.""
What Stock Exchange Does Guerbet Trade On?
Guerbet is listed and trades on the Paris stock exchange.
Is Guerbet a Good Stock to Buy?
Determining whether Guerbet—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRBT quote. (ISIN: FR0000032526)"
25.10
-0.05(-0.20%)
Real-time Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
25.10
25.35
52 wk Range
17.02
40.25
GRBT Scorecard
Full Analysis
Valuation implies a strong free cash flow yield
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
25.1025.35
52 wk Range
17.0240.25
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.99%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.99%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GRBT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
39.90
Upside
+58.96%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has fared poorly over the last month
Guerbet Company Profile
Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab. It also provides digital solutions, such as Contrast&Care, an injection management solution; Dose&Care, an X-ray dose management solution; and icobrain, a cloud-based AI solution to quantify disease-specific brain structures for acute and chronic neurological conditions on MR and CT, as well as OptiProtect services. In addition, the company provides products for interventional radiology, including Lipiodol ethyl esters of iodinated fatty acids of poppyseed oil; Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; Patent Blue V, a blue dye; Axessio, a peripheral micro guidewire; and SeQure and DraKon, which are microcatheters. Further, it offers Hydra Vision, a digital imaging system for urological, gastroenterological, and gynecological treatment, as well as planning and diagnostic procedures; and urology accessories and consumables. Guerbet SA was incorporated in 1926 and is headquartered in Villepinte, France.
Compare GRBT to Peers and Sector
Metrics to compare | GRBT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGRBTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 9.7x | 26.7x | −0.7x | |
PEG Ratio | 0.05 | 0.14 | 0.00 | |
Price/Book | 0.8x | 2.8x | 2.6x | |
Price / LTM Sales | 0.4x | 3.5x | 3.2x | |
Upside (Analyst Target) | 63.0% | 24.4% | 47.1% | |
Fair Value Upside | Unlock | 9.8% | 7.3% | Unlock |
Analysts' Recommendations
5 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 39.90
(+58.96% Upside)
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.6
Dividend Yield
1.93%
Industry Median 1.54%
Annualised payout
0.5000
Paid annually
5-Years Growth
-10.07%
Growth Streak
FAQ
What Is the Guerbet (GRBT) Stock Price Today?
The Guerbet stock price today is 25.10
What Stock Exchange Does Guerbet Trade On?
Guerbet is listed and trades on the Paris stock exchange.
What Is the Stock Symbol for Guerbet?
The stock symbol for Guerbet is "GRBT."
Does Guerbet Pay Dividends? What’s The Current Dividend Yield?
The Guerbet dividend yield is 1.99%.
What Is the Guerbet Market Cap?
As of today, Guerbet market cap is 316.49M.
What is Guerbet Earnings Per Share?
The Guerbet EPS is 2.60.
What Is the Next Guerbet Earnings Date?
Guerbet will release its next earnings report on 26 Mar 2025.
From a Technical Analysis Perspective, Is GRBT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.